Factors that influence physical activity in the daily life of male patients with chronic obstructive pulmonary disease;Fatores que influenciam a atividade física na vida diária dos doentes do sexo masculino com doença pulmonar obstrutiva crónica

Revista Portuguesa de Pneumologia (English Edition)

Volumn 20, Issue 3, 2014, Pages 131-137

  Barriga, S ^a   Rodrigues, F ^b   Barbara C ^b  

^a Centro Hospitalar de Torres Vedras   (Portugal)

^b INSTITUTO DE MEDICINA MOLECULAR   (Portugal)

Author keywords

Activities of daily living; Chronic obstructive pulmonary disease; Pedometer

Indexed keywords

EID: 84904557870     PISSN: None     EISSN: 21735115     Source Type: Journal    
DOI: 10.1016/j.rppneu.2013.09.004     Document Type: Article

References (44)

1. Pitta F, Troosters T, Spruit M, Probst V, Decramer M, Gosselink R. Characteristics of physical activities in daily life in chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2005;171:972 -7.
2. Schonhofer B, Ardes P, Geibel M, Kohler D, Jones PW. Evaluation of a movement detector to measure daily activity in patients with chronic lung disease. Eur Respir J. 1997;10:2814 -9.
3. Haskell W, Lee I, Pate R, Powell K, Blair S, Franklin B, et al. Physical activity and public health: updated recommendation for adults from the American College of Sports Medicine and the American Heart Association. Med Sci Sports Exerc. 2007;39:1423 -34.
4. Pitta F, Troosters T, Spruit M, Probst V, Decramer M, Gosselink R. Quantifying physical activity in daily life with questionnaires and motion sensors in COPD. Eur Resp J. 2006;27:1040 -55.
5. Tudor-Locke C, Burkett L, Reis JP, Ainsworth BE, Macera CA, Wilson DK. How many days of pedometer monitoring predict weekly physical activity in adults? Prev Med. 2005;40:293 -8.
6. Tudor-Locke C, Bassett D. How many steps/day are enough? Preliminary pedometer indices for public health. Sports Med. 2004;34:1 -8.
7. Global Initiative for Chronic Obstructive Lung Disease (GOLD). Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease; 2008.
8. Bestall J, Paul E, Garrod R, Garnham R, Jones P, Wedzicha J. Usefulness of the Medical Research Council (MRC) dyspnoea scale as a measure of disability in patients with chronic obstructive pulmonary disease. Thorax. 1999;54:581 -6.
9. Zigmond A, Snaith R. The hospital anxiety and depression scale. Acta Psychiatr Scand. 1983;67:361 -70.
10. ATS/ERS Task Force. Standards for the diagnosis and treatment of patients with COPD: a summary of the ATS/ERS position paper. Eur Respir J. 2004;23:932 -46.
11. ATS/ERS Task Force: Standardisation of Lung Function Testing. Standardisation of spirometry. Eur Respir J. 2005;26:319 -38.
12. ATS/ERS Task Force: Standardisation of Lung Function Testing. Standardisation of the measurement of lung volumes. Eur Respir J. 2005;26:511 -22.
13. ATS/ERS Task Force: Standardisation of Lung Function Testing. Standardisation of the single-breath determination of carbon monoxide uptake in the lung. Eur Respir J. 2005;26:720 -35.
14. American Thoracic Society. ATS Statement: guidelines for the six-minute walk test. Am J Respir Crit Care Med. 2002;166:111 -7.
15. Borg G. Borg’s perceived exertion and pain scales. Human Kinetics. Copyright © 1998 by Gunnar Borg. ISBN 0-88011-623-4.
16. Celli B, Cote C, Marin J, Casanova C, Oca M, Mendez R, et al. The body-mass index, airflow obstruction, dyspnea, and exercise capacity index in chronic obstructive pulmonary disease. N Engl J Med. 2004;350:1005 -12.
17. Garrod R, Bestall J, Paul E, Wedzicha J, Jones P. Development and validation of a standardized measure of activity of daily living in patients with severe COPD: the London Chest Activity of Daily Living scale (LCADL). Respir Med. 2000;94:589 -96.
18. Pitta F, Probst V, Kovelis D, Segretti N, Leoni A, Garrod R, et al. Validação da versão em português da escala London Chest Activity of Daily Living (LCADL) em doentes com doença pulmonar obstructiva crónica. Rev Port Pneumol. 2008;XIV:27 -47.
19. Watz H, Waschki B, Meyer T, Magnussen H. Physical activity in patients with COPD. Eur Respir J. 2009;33:262 -72.
20. American Thoracic Society. Dyspnea. Mechanisms, assessment and management: a consensus statement. Am J Respir Crit Care Med. 1999;159:321 -40.
21. Gallego M, Samaniego J, Alonso J, Sanchez A, Carrizo S, Marin J. Dyspnea in COPD: relation to the MRC scale with dyspnea induced by walking and cardiopulmonary stress testing. Arch Bronconeumol. 2002;38:112 -6.
22. Cyarto E, Myers A, Tudor-Locke C. Pedometer accuracy in nursing home and community-dwelling older adults. Med Sci Sports Exerc. 2004;36:205 -9.
23. Carter R, Holiday D, Nwasuruba C, Stocks J, Grothues C, Tiep B. 6-Minute walk work for assessment of functional capacity in patients with COPD. Chest. 2003;123:1408 -15.
24. Casaburi R. Activity monitoring in assessing activities of daily living. COPD: J Chron Obstruct Pulmon Dis. 2007;4:251 -5.
25. Wegner R, Jorres R, Kirsten D, Magnussen H. Factor analysis of exercise capacity, dyspnoea ratings and lung function in patients with severe COPD. Eur Respir J. 1994;7:725 -9.
26. Wijkstra P, Vergert E, Marck T, Postma D, Altena R, Kraan J, et al. Relation of lung function, maximal inspiratory pressure, dyspnoea, and quality of life with exercise capacity in patients with chronic ostructive pulmonary disease. Thorax. 1994;49:468 -72.
27. Casaburi R, Porszasz J, Burns M, Carithers E, Chang R, Cooper C. Physiologic benefits of exercise training in rehabilitation of patients with severe chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 1997;155:1541 -51.
28. Engstrom C, Persson L, Larsson S, Ryden A, Sullivan M. Functional status and well being in chronic obstructive pulmonary disease with regard to clinical parameters and smoking: a descriptive and comparative study. Thorax. 1996;51:825 -30.
29. Freitas C, Pereira C, Viegas C. Inspiratory capacity, exercise limitation, markers of severity, and prognostic factors in chronic obstructive pulmonary disease. J Bras Pneumol. 2007;33:389 -96.
30. Marin J, Carrizo S, Gascon M, Sanches A, Gallego B, Celli B. Inspiratory capacity, dynamic hyperinflation, breathlessness, and exercise performance during the 6-minute walk test in chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2001;163:1395 -9.
31. O’Donnell D, Revill S, Webb K. Dynamic hyperinflation and exercise intolerance in chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2001;164:770 -7.
32. Pereira A, Santa-Clara H, Pereira E, Simões S, Remédios I, Cardoso J, et al. Impacto do exercício físico combinado na percepção do estado de saúde da pessoa com doença pulmonar obstructiva crónica. Rev Port Pneumol. 2010;XVI:737 -57.
33. Ringbaek T, Lange P. Outdoor activity and performance status as predictors of survival in hypoxaemic chronic obstructive pulmonary disease (COPD). Clin Rehabil. 2005;19:331 -8.
34. Tudor-Locke C, Ham S, Macera C, Ainsworth B, Kirtland K, Reis J, et al. Descriptive epidemiology of pedometer-determined physical activity. Med Sci Sports Exerc. 2004;36:1567 -73.
35. Tudor-Locke C, Ainsworth B, Whitt M, Thompson R, Addy C, Jones D. The relationship between pedometer-determined ambulatory activity and body composition variables. Intern J Obesity. 2001;25:1571 -8.
36. Van Ede L, Yzermans C, Brouwer H. Prevalence of depression in patients with chronic obstructive pulmonary disease: a systematic review. Thorax. 1999;54:688 -92.
37. Breslin E, Van der schans C, Breukink S, Meek P, Mercer K, Volz W, et al. Perception of fatigue and quality of life in patients with COPD. Chest. 1998;114:958 -64.
38. Olsson I, Mykletun A, Dahl A. The hospital anxiety and depression rating scale: a cross-sectional study of psychometrics and case finding abilities in general practice. BMC Psychiatry. 2005;5:46 -52.
39. Yohannes A, Roomi J, Baldwin R, Connolly M. Depression in elderly outpatients with disabling chronic obstructive pulmonary disease. Age Ageing. 1998;27:155 -60.
40. Alvarez-Gutierrez F, Miravitlles M, Calle M, Gobartt E, Lopez F, Martin A, on behalf of EIME Study Group. Impact of chronic obstructive pulmonary disease on activities of daily living: results of the multicenter EIME study. Arch Bronconeumol. 2007;43:64 -72.
41. Garrod R, Paul EA, Wedzicha JA. An evaluation of the reliability and sensitivity of the London Chest Activity of Daily Living Scale (LCADL). Respir Med. 2002;96:725 -30.
42. Simon KM. Atividade de vida diária e índice de mortalidade ‘‘BODE’’ em indivíduos portadores de doença pulmonar obstrutiva crónica. Uberlândia: Dissertação apresentada ao programa de mestrado em fisioterapia; 2006.
43. Bárbara C, Rodrigues F, Dias H, Cardoso J, Almeida J, Matos MJ, et al. COPD prevalence in Lisbon, Portugal: the Burden of Obstructive Lung Disease. Rev Port Pneumol. 2013;19: 96 -105.
44. Van Remoortel H, Giavedoni S, Raste Y, Burtin C, Louvaris Z, Gimeno-Santos E, et al., on behalf of PROactive Consortium. Validity of activity monitors in health and chronic disease: a systematic review. Int J Behav Nutr Phys Act. 2012;9:84. http://www.ijbnpa.org/content/9/1/84